@Iryna-Bella, I think they are simply behaving as you would expect, with the global outlook so hard to read. These guys want cash on hand if the Omicron story turns bad once the detailed data is in by end of December (or before). IMO, and judging by some of the data we have been given, Omicron will be a blip on the radar for the double-vaxxed (and preferably boostered). NSW infections increased 4 fold over the 5 days to Sunday yet the ICU population moves less than 10% (and how many of these are Delta we don't know).
Bell Potter, 'our' analyst, had also seriously undervalued the stock in the past few weeks or so.
